A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure
Critical Care volume 24, Article number: 337 (2020)
To the Editor,
In early February 2020, Yang et al.  reported an alarming high mortality rate in patients with COVID-19-associated acute respiratory failure requiring mechanical ventilatory support. Such a dreadful outcome was regarded as the fundamental tenet dictating our strategy to treat patients with COVID-19 acute respiratory failure. Two essential recommendations were offered to the medical community in keeping with these first reports: (1) early intubation of hypoxemic patients . Indeed, since a profound hypoxemia appears to be the hallmark of COVID-19-associated pneumonia, the initial consensus  was to start invasive mechanical ventilation as soon as possible due to the overwhelming number of patients in respiratory failure presenting at the same time in a hospital and to prevent the risk of hypoxic cardiac arrest; (2) avoidance of high-flow nasal cannula (HFNC) to reduce respiratory droplet aerosolization for healthcare workers  in what was seen as “inevitable” intubations.
During the very initial weeks preceding the anticipated surge in central Pennsylvania, ten patients with confirmed infection by SARS-CoV-2, who had extremely high oxygen requirement, were admitted in our institution (Harrisburg/Hershey region): all patients required a high flow of oxygen by nasal cannula (NC) or via non-rebreather (NRB) (Fig. 1) with documented episodes of SpO2 < 90%. The first four patients underwent endotracheal intubation by day 2 of hospital admission without a trial of high flow nasal cannula (HFNC) or non-invasive ventilation (NIV), following the recommendations for early intubation . However, we reconsidered in other patients the rationale behind these early intubations and revisited the initial proposal of avoiding high flow oxygen in hypoxemic patients. In addition, we felt that the actual consequences of aerosolization posed by HFNC and NIV  remain quite hypothetical as reported in H1N1 pneumonia . Our main concern was that a systematic intubation of every hypoxemic patient may prove to be untenable, facing a limitation of capacity and resources of intensive care units (ICU) to safely maintain a high number of patients on mechanical ventilation during the expected surge. We therefore selected a different strategy in the following six patients whose initial oxygen requirement was in the same range as the patients who were intubated by day 2. Empiric limit of hypoxic events ~ 88% was considered acceptable as long as the SpO2 was maintained at or above this level during most of the day and could be improved by self-prone positioning. This strategy was adopted in the absence of preexisting chronic respiratory failure, morbid obesity, concurrent clinical signs of respiratory distress, hypercapnia, alteration in hemodynamics, or lactic acidosis. We used a flow of oxygen up to 6 L/min NC and HFNC whenever higher FiO2 was needed (Fig. 1). Out of these six patients, two required invasive mechanical ventilation after failing HFNC: one patient developed respiratory fatigue and required intubation at day 3, while the second patient had intolerance to NIV and self-prone positioning with an episode of emesis that led to intubation on day 6. The non-intubated patients were instructed to rest in a prone position as much as feasible. After an initial increase in oxygen requirement through day 6, patients in this group were all able to be discharged at a time when most of the early-intubated patients were still mechanically ventilated (Fig. 1). Strikingly, this occurred despite similar initial oxygen requirements.
In summary, avoiding endotracheal intubation is possible in significantly hypoxemic COVID-19 patients. The rationale that led to the practice patterns suggested in earlier reports must be reevaluated, and a controlled graduated method of escalating oxygen therapy, based on individual clinical judgment, in otherwise non-distressed patients should be instituted as much as possible. Such an approach remains to be standardized.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Yang X, Yu Y, Xu J, Shu H, Xia JA, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81.
WHO. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. 2020. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf (Accessed 17 Apr 2020).
Cheung JC, Ho LT, Cheng JV, Cham EYK, Lam KN. Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med. 2020;8(4):e19.
Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7(4):e35797.
Rello J, Pérez M, Roca O, et al. High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J Crit Care. 2012;27(5):434–9.
No funding was required for the development of this manuscript.
Ethics approval and consent to participate
The work did not require approval from ethics committee.
Consent for publication
No consent was required in the elaboration of this research.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Villarreal-Fernandez, E., Patel, R., Golamari, R. et al. A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure. Crit Care 24, 337 (2020). https://doi.org/10.1186/s13054-020-03063-6